Reports

• CMS Has Limited Oversight of Selected Compounded Drugs Prescribed to Medicare Part D Enrollees

  

• Vibrent Health Claimed Unallowable Costs Under a National Institutes of Health Other Transaction Award

  

• Louisiana Healthcare Connections Generally Complied With Federal and State Process Requirements When Denying Prior Authorization Requests

  

• Medicare Advantage Compliance Audit of Specific Diagnosis Codes That Priority Health (Contract H2320) Submitted to CMS

  

• Medicare Home Health Agency Provider Compliance Audit: VNS Health

  

• Selected Diabetes and Weight Loss Drugs Were Dispensed to Michigan Medicaid Managed Care Enrollees in Accordance With Federal and State Requirements

  

• Congressional Mandate: Part B Payment Amounts for One Drug Included Noncovered Self-Administered Versions in 2024

  

• Review of the Department of Health and Human Services’ Compliance With the Federal Information Security Modernization Act of 2014 for Fiscal Year 2025

  

• Medicaid Fraud Control Units Annual Report: Fiscal Year 2025

  

• Indiana Generally Ensured That Selected Nursing Homes Complied With Federal Background Check Requirements

  

• Nursing Homes Inappropriately Diagnosed Residents with Schizophrenia to Mask the Misuse of Antipsychotic Drugs

  

• Medicare Advantage Compliance Audit of Specific Diagnosis Codes That Gateway Health Plan, Inc., (Contract H5932) Submitted to CMS

  

• Medicare Advantage Compliance Audit of Specific Diagnosis Codes That Blue Cross and Blue Shield of Alabama (Contract H0104) Submitted to CMS

  

• Psychosocial Characteristics and Their Association With Kidney Transplant Programs Waitlist Rates

  

• Emergency Department Procedure Codes Used on Medicare Claims for Services Billed With Nonemergency Department Sites of Service Resulted in Over $15 Million in Improper and Potentially Improper Payments

  

• Colorado Made at Least $77.8 Million in Improper Fee-for-Service Medicaid Payments for Applied Behavior Analysis Provided to Children

  

• Centers for Disease Control and Prevention Fiscal Year 2025 Detailed Accounting Submission and Fiscal Year 2027 Budget Formulation Compliance Report for National Drug Control Activities, and the Accompanying Required Assertions

  

• Food and Drug Administration Fiscal Year 2025 Detailed Accounting Submission and Fiscal Year 2027 Budget Formulation Compliance Report for National Drug Control Activities, and the Accompanying Required Assertions

  

• National Institutes of Health Fiscal Year 2025 Detailed Accounting Submission and Fiscal Year 2027 Budget Formulation Compliance Report for National Drug Control Activities, and the Accompanying Required Assertions

  

• Alaska Missed Opportunities to Protect American Indian and Alaska Native Children Missing from Foster Care